Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Masimo Corporation

StethoMe is engaged in the development of a smart stethoscope that enables home-based monitoring of respiratory sounds, particularly for patients with chronic respiratory conditions like asthma. This technology involves artificial intelligence for sound analysis.

StethoMe

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc.

Sky Medical Technology partners with clinicians to develop cutting-edge medical products and evidence-based therapies aimed at improving patient outcomes and simplifying treatments.

Sky Medical Technology

Masimo develops innovative noninvasive monitoring technologies for personal and professional health applications, including wearable devices and pulse oximeters. The technologies are used in both home and hospital settings.

Metric
Company Name	Masimo Corporation	StethoMe	ResMed Inc.	Sky Medical Technology
Symbol	MASI		RMD
MSH ID	COM:MASIMO	COM:STETHOME	COM:RESMED	COM:SKYMEDTECH
Market	STOCKS	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Technology	Medical - Instruments & Supplies	Medical Technology
Country	US	PL	US	GB
Stage
Employee Count	3.80K		10.14K
Website	masimo.com	stethome.com	resmed.com	skymedtech.com
LinkedIn			resmed
Founders

Metric
Market Cap	5.69B		28.25B
Enterprise Value
Monthly Web Traffic	193.91K	2.76K
Web Traffic Growth	0.29	2.15
Valuation
Raised Capital	750M	1.21M

Metric
Revenue	2.05B	4.69B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.00B	2.62B
EBITDA	262.60M	1.69B
Operating Income	164.30M	1.40B
Net Income	81.50M	1.02B
EPS	1.54	6.94
Diluted EPS	1.51	6.92
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.49	0.58
Operating Profit Margin	0.08	0.29
EBITDA Margin	0.13	0.36
Net Profit Margin	0.04	0.22
Return on Equity	0.06	0.22
Return on Assets	0.03	0.15
Return on Capital Employed	0.06	0.22

COM:MASIMO

Masimo

Last Close

169.12

22/11 21:00

Market Cap

5.69B

Beta: -

Volume Today

817.42K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	79.31	31.53
P/B Ratio	5.50	6.26
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.84	8.17
EV Multiple	27.18	22.65

Metric
Days Sales Outstanding	61.56	61.02
Days Payables Outstanding	97.44	39.24
Days Inventory Outstanding	190.43	180.93
Operating Cycle	266.68	241.95
Cash Conversion Cycle	193.68	202.71
Asset Turnover	0.70	0.66

Metric
Operating Cash Flow	94.10M	1.40B
Free Cash Flow	6.40M	1.29B
Cash Flow to Debt	0.24	1.91
Operating Cash Flow/Sales	0.09	0.31
Free Cash Flow Yield	-0.01	0.03

Metric
Cash & Equivalents	166M	238.36M
Accounts Receivable	91.90M	-134.28M
Inventory	545M	822.25M
Goodwill	407.70M
Debt to Capitalization	0.41	0.24
Debt to Assets	0.32	0.20
Current Ratio	2.14	3.11
Quick Ratio	1.31	1.97

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00	0.02
R&D to Revenue	0.09	0.07
SG&A to Revenue